NR3C1 and familial pancreatic carcinoma: In addition, when we treated pancreatic cancer cells with gemcitabine, the expression of FKBP5 as well as GR was upregulated in a dose dependent manner (Figure S3B), even when GR expression was initially knocked-down in these cells (Figure S3C).